Senior insider sale
Chief Scientific Officer at ARBUTUS BIOPHARMA CORP — senior position signals high conviction
$2.05M
633.81K shares
SOFIA MICHAEL J. plans to sell 633.81K shares of ARBUTUS BIOPHARMA CORP valued at approximately $2.05M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Merger Acquisition
Cash/Check
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/26/2012 | Merger Acquisition Cash/Check | 250K | — |
| Total | 250K | ||
Completed
Units to sell
50K
Market value
$164.6K
Units to sell
50K
Market value
$164.8K
Units to sell
50K
Market value
$161.0K
Units to sell
12.64K
Market value
$39.8K
Units to sell
4K
Market value
$13.6K
Units to sell
50K
Market value
$170.6K
Units to sell
157.16K
Market value
$481.3K
Units to sell
10K
Market value
$33.6K
Planned — Approximate Date
Units to sell
250K
Market value
$820.0K
Units
633.81K
Value
$2.05M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/21/2025 | 50K | $164.6K | — | Completed |
3/20/2025 | 50K | $164.8K | — | Completed |
3/19/2025 | 50K | $161.0K | — | Completed |
3/18/2025 | 12.64K | $39.8K | — | Completed |
3/14/2025 | 4K | $13.6K | — | Completed |
3/14/2025 | 50K | $170.6K | — | Completed |
3/11/2025 | 157.16K | $481.3K | — | Completed |
3/7/2025 | 10K | $33.6K | — | Completed |
| Planned — Approximate Date | ||||
3/24/2025 | 250K | $820.0K | nasdaq | Planned |
| Total | 633.81K | $2.05M | ||